Daniel-Adriano Silva

Dr. Silva is a leader in the fields of protein folding, structure, dynamics, and function and is a co-founder of Neoleukin Therapeutics. From 2019 to February 2021, he served as Vice President, Head of Research at Neoleukin. Prior to that, he served as a Translational Investigator in the Department of Biochemistry at the University of Washington. In 2013, Dr. Silva received a Pew Latin American postdoctoral fellowship to train with David Baker at the University of Washington, where he developed state-of-the-art de novo protein design algorithms. Dr. Silva has co-authored more than 30 published research articles, including in Science, Nature and PNAS. He graduated from the National Autonomous University of Mexico and completed his initial postdoctoral training at the Hong Kong University of Science and Technology, where he developed tools to study protein-ligand binding dynamics.